Company Search:
Advanced Search
Sponsored Links
Corcept Therapeutics Incorporated Company Snapshot
Corcept Therapeutics Incorporated operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Corcept Therapeutics Incorporated with three other companies in this sector in the United States: Xencor Inc (2016 sales of $87.52 million of which 100% was Medicine Manufactur), Lexicon Pharmaceuticals Incorporated ($83.34 million of which 100% was Pharmaceutical R&D), and Ptc Therapeutics Inc ($82.71 million of which 100% was Bio Pharmaceutical).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Corcept Therapeutics Incorporated
  Stock Performance Chart for Corcept Therapeutics Incorporated
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 23.98
(Figures in U.S. Dollars)
1 Week 16.1%   13 Weeks 34.0%  
4 Weeks 30.4%   52 Weeks 224.1%  
Corcept Therapeutics Incorporated Key Data:
  Ticker: CORT Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 81,321,000
(Year Ending Jan 2017).
Employees: 103
  Currency: U.S. Dollars Market Cap: 2,736,697,381
  Fiscal Yr Ends: December Shares Outstanding: 114,124,161
  Share Type: Common Closely Held Shares: 10,950,936
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.